2TZ.F Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Healthcare Drug Manufacturers - Specialty & Generic Frankfurt Exchange
- EUR
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
14.35%
Fundamental score
-

Is 2TZ.F undervalued?

Graham number

The Graham number of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited fundamental analysis

No fundamental analysis for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited yet.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was …

Full company profile